Trusted Resource for Clinical Trials, Protocols & Progress
Emerging Tools for Phase 4 Signal Detection: Enhancing Pharmacovigilance Through Innovation Innovative Technologies and Strategies for Signal Detection in Phase 4 Clinical Trials Introduction Signal detection is at the heart of pharmacovigilance during Phase 4 clinical trials, where real-world use of a drug may reveal new safety concerns not identified in pre-approval studies. With increasing…
How to Conduct a CRO Qualification Visit Step-by-Step Guide to Conducting a CRO Qualification Visit Before selecting a Contract Research Organization (CRO) for clinical trial services, sponsors must perform due diligence through a qualification visit. A CRO qualification visit—often referred to as a pre-study or vendor audit—is a formal evaluation to verify the CRO’s capabilities,…
Regulatory Requirements for Inclusive Recruitment in Clinical Trials Understanding Regulatory Requirements for Inclusive Recruitment in Clinical Trials In recent years, regulatory bodies across the globe have emphasized the need for increased diversity and inclusion in clinical trial recruitment. Inclusive recruitment ensures that study outcomes are generalizable and equitable across diverse populations—especially those historically underrepresented in…
Read More “Regulatory Requirements for Inclusive Recruitment in Clinical Trials” »
Adapting SOPs for Decentralized Study Procedures in Clinical Trials How to Adapt SOPs for Decentralized Clinical Trial Procedures Standard Operating Procedures (SOPs) are the backbone of any Good Clinical Practice (GCP)-compliant study. With the rapid adoption of decentralized clinical trials (DCTs), where traditional site-based visits are replaced with home health visits, telemedicine, and digital tools,…
Read More “Adapting SOPs for Decentralized Study Procedures in Clinical Trials” »
Defining Open-Label Trial Structures and Use Cases – Clinical Trial Design and Protocol Development “Exploring the Framework and Applications of Open-Label Trials” Introduction to Open-Label Trials Open-label trials, also known as unblinded studies, are a type of clinical research study where both the researchers and the participants are aware of the treatment or intervention being…
How to Build Enrollment Metrics Dashboards for Clinical Trial Monitoring Efficient patient recruitment is the heartbeat of successful clinical trials. Yet, many clinical operations teams struggle to monitor enrollment progress in real-time due to siloed data and outdated reporting tools. Enrollment metrics dashboards solve this by providing interactive, visual snapshots of recruitment KPIs that drive…
Read More “Building Enrollment Metrics Dashboards for Clinical Trials” »
Impact of Phase 4 Studies on Clinical Practice Guidelines How Phase 4 Clinical Trials Shape and Influence Clinical Practice Guidelines Introduction Phase 4 clinical trials, also known as post-marketing studies, are instrumental in shaping real-world medical practice. Beyond safety surveillance and regulatory compliance, these trials generate robust data that influence clinical practice guidelines (CPGs) issued…
Read More “Impact of Phase 4 Studies on Clinical Practice Guidelines” »
Defining Vulnerable Populations in Clinical Research and Their Additional Protections Understanding Vulnerable Populations in Clinical Research and Ensuring Their Ethical Protection In clinical research, vulnerable populations are individuals or groups who may be at increased risk of coercion, undue influence, or harm due to their physical, mental, economic, or social circumstances. Ethics Committees (ECs) and…
Read More “Defining Vulnerable Populations in Clinical Research and Their Additional Protections” »
Best Practices for Documenting SDV in Clinical Monitoring Reports Source Data Verification (SDV) is a core function of clinical monitoring. However, even perfectly executed SDV can lose its value if not appropriately documented in the Monitoring Visit Report (MVR). Regulatory authorities such as the USFDA and CDSCO emphasize that proper documentation of SDV activities is…
Read More “How to Document Source Data Verification (SDV) in Monitoring Reports” »
Therapeutic Experience vs Operational Capability in CRO Selection Weighing Therapeutic Experience vs Operational Capability in CRO Selection When selecting a Contract Research Organization (CRO) to manage a clinical trial, sponsors often face a pivotal question: should we prioritize therapeutic expertise or operational capability? Both dimensions are essential, but striking the right balance can be challenging….
Read More “Therapeutic Experience vs Operational Capability in CRO Selection” »
